baber/WOPTO huggingface dataset:
Patent IL-84023-A0 (IL)
Title: Crosslinked polyacrylamide-sulfhydryl gel and derivatives thereof and their preparation
IPC: C08F20/56
Filed: 1987-09-29
Abstract: A water-insoluble, crosslinked polyacrylamide copolymer comprising crosslinked polyacrylamide copolymer chains of recurring monomeric structural units comprising residues of acrylamide, bisacrylamide or analogs thereof, and N,N'-bisacrylylcystamine or analogs thereof. The crosslinked copolymer can be formed into discrete particles characterized by having crosslinking disulfide groups on their external surface which can be reduced to provide exposed chemically active sulfhydryl groups. The activated polyacrylamide particles can be reacted with suitable haptens and other biologically active substances to provide insolubilized forms thereof.
Patent IL-90739-A0 (IL)
Title: Carbohydrate cream substitute
IPC: A23C9/12
Filed: 1989-06-23
Abstract: A fat substitute is disclosed which comprises water-dispersible macrocolloid particles composed of carbohydrate materials which particles have a substantially spheroidal shape and a particle size distribution effective to impart the substantially smooth organoleptic character of an oil-and-water emulsion.
Patent IL-93819-A0 (IL)
Title: Child resistant container for storing hazardous materials
IPC: B65D50/04
Filed: 1990-03-20
Abstract: A child resistant box (20) which is composed of a base (23), a lid (22) and a hinge (30) connecting the base (23) and lid (22) together. A latching mechanism is located on each of the two sides of the box for releasably retaining the lid (22) to the base (23). The box (20) can be moved between open, intermediate, and closed positions. The box (20) also includes a means for biasing the lid from the intermediate position toward the closed position. To open the box (20) the lid (22) is compressed to the intermediate position. In this intermediate position, the latching mechanism may be disengaged by exerting manual pressure thereon toward the center of the box (20). Once pressure is exerted simultaneously on both latching mechanisms the lid (22) is released and the biasing means moves the lid (22) at least partially toward the open position. The operation of this box (20) is particularly well-suited for the elderly. Although this child resistant box can house virtually anything, it is particularly well suited for housing a set of blister cards which include a plurality of medicaments to be taken at different times during a therapeutic regimen.
Patent AU-PM534794-A0 (AU)
Title: Modified milk growth factor
IPC: A61P1/04
Filed: 1994-04-28
Abstract: The invention provides a process for preparing a plurality of modified milk growth factors which process includes: providing a milk product extract including a plurality of milk growth factors having basic to approximately neutral isoelectric points and a source of acid; subjecting the milk product extract to transient acidification utilising the acid source; and isolating a plurality of modified milk growth factors from the transiently acidified milk product extract. Also provided are growth promoting compositions, cell culture compositions, and pharmaceutical or veterinary compositions for the treatment of surface wounds, gastrointestinal injuries, diseases or ulcers, each including a plurality of modified milk growth factors having isoelectric points above approximately 6.0 and molecular weights in the range of approximately 5000 to 30.000, the milk growth factors being modified by transient acidification.
Patent AU-PR244901-A0 (AU)
Title: A method (WSM02)
IPC: H01L23/08
Filed: 2001-01-10
Abstract: The invention is a method of forming an array of caps for attachment to a wafer which includes a plurality of microfabricated devices. The method includes sandwiching a sheet (134) of thermoplastic material between upper and lower molds (102, 104), heating the sheet to a plastic state and molding the sheet into caps. The molds (102, 104) are preferably formed of silicon and infrared radiation is preferably used to heat the sheet (134).
Patent FI-20012139-A0 (FI)
Inventor: KNUUTTILA OLLI
IPC: G08G1/01
Filed: 2001-11-05
Abstract: The invention relates to collecting of traffic data with the aid of a mobile station network. Such areas are determined in the mobile station network, wherein the terminal equipment communicates with the network with the aid of one or more predetermined messages. Based on the message between the network and terminal equipment and relating to a first area a first time by the clock is stored, and based on the message between the network and the same terminal equipment and relating to a second area a second time by the clock is stored. The times by the clock are used in order to obtain traffic data by calculating, for example, the time spent on moving from one area to another. By determining the distance between areas along the road it is possible also to determine the speed of the vehicle. Information may also be collected to form a statistic distribution.
Patent FI-20012191-A0 (FI)
Inventor: GARCIA-MARTIN MIGUEL-ANGEL
IPC: H04W99/00
Filed: 2001-11-12
Abstract: The present invention relates in general to telecommunication networks and more specifically to a method and an arrangement for signalling in a wireless IP multimedia network and to a wireless IP multimedia network terminal device. With the help of the solution according to the presented invention 3GPP Core Network IP Multimedia Subsystem and all the products associated with that i.e. terminals, Media Gateway, Media Gateway Control Function, etc. can to support DTMF tones. <IMAGE>
Patent FI-20021188-A0 (FI)
Inventor: HEMMILAE MIKKO PETTERI
IPC: C21D1/18
Filed: 2002-06-19
Abstract: A hot-rolled steel strip rolled to a final thickness that is at least 2 mm but no more than 12 mm, with a microstructure comprising at least 95 % martensite and/or bainite. The steel contains, in percentages by weight: 0.08 % - 0.16 % C, 0.5 % - 1.5% Cr and/or 0.1 % - 0.5 % Mo, ≤ 0.015 % S and ≤ 0.03 % P, 0.01 % - 0.08 % Al, as well as 0.6 % - 1.1 % Mn, and 0.1 % - 0.3 % Si, the rest being Fe and unavoidable impurities. The tensile strength of the steel strip is 700 Mpa - 1500 Mpa at a tensile elongation that has an A5 value of at least 6 %, and the yield strength is 600 Mpa - 1400 Mpa.
Patent FI-20055321-A0 (FI)
Inventor: RATA ILKKA
IPC: D21G/
Filed: 2005-06-17
Abstract: A composite doctor arrangement which is intended for a web forming machine or web handling machine. The doctor arrangement comprises a beam structure (10) and a mounting piece (13) fitted to it, as well as a blade holder (11) fitted to the mounting piece, with a blade (12) included in the doctor arrangement fitted to the blade holder (11). The mounting piece (13) is fitted axially and movably in the beam structure (10) by means of a form-locked mounting counterpiece (14), where the form locking is arranged so that it is fixed in the lateral direction of the blade (12) and essentially free in the longitudinal direction of the blade (12).
Patent FI-20086093-A0 (FI)
Inventor: HAKALA OLLI
IPC: A61K35/742
Filed: 2008-11-19
Abstract: The present invention concerns an intravaginal delivery system, said system comprising at least one compartment comprising a core and a membrane encasing the core, wherein the core and the membrane essentially consist of a same or different polymer composition. Additionally the intravaginal delivery system comprises a coupling means to form a closed continuous delivery system. The present invention also concerns a method for manufacturing said intravaginal delivery system. The core and/or the membrane are preferably prepared by injection moulding or by extrusion.
Patent IL-106672-A0 (IL)
Title: 9-((substituted glycyl)amino))-6-demethyl-6-deoxytetracyclines
IPC: C07C/
Filed: 1993-08-12
Abstract: The invention provides compounds of the formula: <CHEM> wherein R, R<1> and W are defined in the specification. These compounds are useful as antibiotic agents.
Patent IL-108923-A0 (IL)
Title: Naphthalene derivatives
IPC: C07D215/14
Filed: 1994-03-10
Abstract: Compounds of formula (I) where R1 is of formulae (II), (III), or (IV), or (V); R2 is -R4, -O-R4, -O-S(O)2-R4, -NR4R5, R4-(CH2)b-NH(C=X)-(CH2)c-, R4-(CH2)b-O(C=O)NH-(CH2)c-(C=O)NH-, R4-(C=O)NH-(C=O)NH-, -(CH2)b-NH(C=X)-(CH2)c-R4, R4-(CH2)b-O(C=O)-(CH2)c-, -(CH2)b-O(C=O)-(CH2)c-R4, -NH(C=X)NH-R4, R4-O(C=O)O-, -O(C=O)NH-R4, R4-O(C=O)NH-, -(CH2)b-(C=O)-(CH2)c-R4, -NH-S(O)2-R4, -C(OH)R4R5, -CH(OH)-R4, -(C=O)-NR4R5, -CN, -NO2, substituted C1 to C6 alkyl, substituted or unsubstituted C1 to C6 alkenyl, or substituted or unsubstituted C1 to C6 alkynyl, said substituted moieties substituted with a moiety of the formulae -R4, -R4R5, -O-R4, or -S(O)d-R4; R3 is hydrogen, C1 to C6 alkyl, C1 to C6 alkylaryl, or aryl; R4 and R5 are each independently (XV), (XVI), (XVII), hydrogen, -CF3, C1 to C6 alkyl, C1 to C6 alkylaryl, with the proviso that when R2 is -R4 or -OR4, R4 is not hydrogen or C1 to C6 alkyl. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and antagonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent IL-116511-A0 (IL)
Title: Mutant enzymes
IPC: C12P21/08
Filed: 1995-12-22
Abstract: PCT No. PCT/GB95/02991 Sec. 371 Date Jun. 23, 1997 Sec. 102(e) Date Jun. 23, 1997 PCT Filed Dec. 21, 1995 PCT Pub. No. WO96/20011 PCT Pub. Date Jul. 4, 1996A two component system for therapeutic treatment of a host, having a first component comprising a targeting moiety capable of binding with a tumour associated antigen, linked to a mutated enzyme capable of converting a prodrug into an antineoplastic drug, and a second component comprising a prodrug convertible under the influence of the mutated enzyme to the antineoplastic drug. The mutated enzyme is a mutated form of a natural host enzyme which recognizes its natural substrate by an ion pair interaction with the substrate, wherein the mutated enzyme and prodrug have structures such that the polarity of the mutated enzyme/prodrug ion pair interaction is reversed relative to the natural host enzyme/natural substrate ion pair interaction. The first component is substantially non-immunogenic in the host and the prodrug second component is not significantly convertible into antineoplastic drug in the host by natural unmutated host enzyme.
Patent IL-119643-A0 (IL)
Title: Infant safety seat
Inventor: DREXLER JOHANNES HERMAN
IPC: B60N2/28
Filed: 1996-11-19
Abstract: An infant safety seat of the type, comprising a bucket seat body (1) having a supporting bottom and a pivotable carrying handle and provided with attachment points for the hip belt portion and the shoulder belt portion respectively of a threepoints-safety belt (8). Between the support bottom surface and the seat surface thereabove there is a transverse through belt receiving space adjacent the front side of the bucket seat body (1), said space being delimited at the front side by a transverse and upstanding belt holding surface, that is accessible for a belt from an end of the bucket seat body (1). <IMAGE>
Patent IL-127574-A0 (IL)
Title: Inhibitors of prenyl transferases
IPC: A61P9/08
Filed: 1997-05-06
Abstract: A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by one of the two following formulas:   <IMAGE>    <IMAGE>   Each of the R groups is defined in the disclosure.
Patent IL-138301-A0 (IL)
Title: Liquid, radiation- curable composition, especially for producing flexible cured articles by stereolithography
IPC: B29C67/00
Filed: 1999-03-19
Abstract: The present invention relates to stereolithographic compositions containing an actinic radiation-curable and cationically polymerizable organic substance, a cationic initiator, a radical photoinitiator, and at least one cationic reactive modifier containing at least two reactive groups per molecule or at least one polyether polyol or mixtures thereof. The cationic reactive modifier has at least one chain extension segment with a molecular weight of at least about 100 and not more than about 2,000. The polyether polyol has a molecular weight greater than or equal to about 4,000. The use of the cationically reactive modifiers and polyether polyol modifiers substantially increases the flexibility and toughness of the cured articles without compromising photospeed, accuracy and wetting-recoatability of the compositions. The present invention further relates to a method of producing a cured product, particularly three-dimensional shaped articles by treating the composition described above with actinic radiation.
Patent IL-140028-A0 (IL)
Title: Patient specific dosimetry
IPC: A61N5/10
Filed: 1999-06-04
Abstract: A patient-specific optimally effective radiation dose for administration of a radiopharmaceutical to a patient for treatment of a disease may be established by basing the calculation of the appropriate therapeutic dose on factors such as the desired total body dose, the maximum tolerated dose, the typical clearance profile of the radiopharmaceutical, the patient's mass or maximum effective mass, and the patient-specific residence time of the radiopharmaceutical or an analog in the whole body of the patient. The use of the method allows for treatment of a patient with an appropriate dose which is maximally effective against the disease yet minimally toxic. The determination of a patient-specific therapeutic dose may be assisted by the use of a software program set to the particular parameters of the radiopharmaceutical. <IMAGE>
Patent IL-164405-A0 (IL)
Title: A composition containing 4,1',6'-trichloro-4,1',6'-trideoxygalactosucrose
IPC: A23L2/60
Filed: 2003-04-04
Abstract: Abstract of the Disclosure The present invention teaches novel compositions and methods for altering the sweetness delivery profile of 4,1',6'-trichloro-4,1',6'-trideoxygalactosucrose. This invention also teaches novel uses for compositions comprising 4,1',6'-trichloro-4,1',6'-trideoxygalactosucrose.
Patent IL-164736-A0 (IL)
Title: Frozen aerated product in a container
IPC: A23G9/32
Filed: 2004-10-20
Abstract: A frozen aerated product is filled into a container having at least two compartments (A) and (B), said compartments being gastighlty separated from each other by an at least partially movable wall, compartment (A) containing a propellant and compartment (B) containing the frozen aerated product, compartment (B) being provided with a valve, wherein the propellant is first introduced into compartment (A), up to where a pressure of at between 1 barg and 10 barg is reached, then the frozen aerated product is introduced into compartment (B) until a pressure of between 5 barg and 12 barg, preferably above 8 barg, is reached.
Patent IL-176569-A0 (IL)
Title: Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
IPC: A61K31/4745
Filed: 2006-06-26
Abstract: The subject invention provides stereoisomeric compounds of formula (x): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
Patent IL-180126-A0 (IL)
Title: Method and apparatus for retaining screws in a plate
IPC: A61B17/70
Filed: 2006-12-17
Abstract: A retention system for maintaining a screw to a vertebral plate is described herein. One or more screws extend through apertures within the vertebral plate. A cavity is positioned adjacent to and overlaps into the aperture. A ring is positioned within the cavity and held in position by a cap. The cap attaches to the plate to prevent removal of the ring. The ring is deflectable between a first shape to allow the screw to be inserted and removed from the aperture, and a second shape to prevent screw back-out from the aperture.
Patent RO-129647-A0 (RO)
Title: Method for using purification sludges in ferrous metallurgy
Inventor: GURĂU GHEORGHE
IPC: C02F11/06
Filed: 2014-03-19
Abstract: The invention relates to a method for introducing sludge from a waste water purification plant into the primary flow sheet of integrated iron and steel works, the sludge being used as both auxiliary fuel and starting material. According to the invention, the method consists in converting the sludge into powder through thermal and mechanical processing, introducing the powder into the sintering process together with the coke powder in the batcher bunker (1), mixing it along with the other components of the agglomerate charge within the homogenizing apparatus (2), transferring the charge to the agglomeration belt (4) where, by heat application and mineral content, it takes part in the sintering process, is embedded into the agglomerate reaching further the bunker scaffold (6) and then the blast furnace (7).
Patent MC-1829-A1 (MC)
Inventor: HANS REINHARD KNEPPER
IPC: G05D1/02
Filed: 1986-10-14
Abstract: PCT No. PCT/CH86/00143 Sec. 371 Date Jun. 10, 1987 Sec. 102(e) Date Jun. 10, 1987 PCT Filed Oct. 14, 1986 PCT Pub. No. WO87/02483 PCT Pub. Date Apr. 23, 1987.A method and an apparatus for automatically steering a vehicle intermittently associated with a stationary guide structure. A sensor detects the distance between the vehicle and the guide structure to provide an actual value signal, which is compared with a reference signal to effect feedback control over vehicle movement. The referenece signal is adjustably controlled periodically when required, e.g., when the vehicle has completed a circuit within the area of interest.
Patent MA-23001-A1 (MA)
IPC: C11D9/48
Filed: 1993-10-12
Abstract: The present invention relates to personal cleansing bar made with a base soap tailored with mixed counterions (Mg/K/Na) and selected saturated C14-C18 fatty acid soaps and soap selected from lauric, oleic, and other minor selected more soluble soaps. The personal cleansing bar of this invention has improved mildness while maintaining acceptable lathering/sudsing, rinsing and processing characteristics.
Patent MA-26843-A1 (MA)
Inventor: GRAY GEORGES
IPC: A61P15/08
Filed: 2002-05-13
Abstract: The present invention relates to the field of therapeutic chemistry and more especially to the realization of new galenic forms intended to be applied on the skin. More particularly it relates to a topical hormonal composition with a systemic effect for the hormonal treatment of the perimenopause and of the menopause as well as for the treatment of the ovarian hormonal deficiencies in women with amenorrhea, characterized in that it comprises, as active ingredients, a progestogen derived from 19-nor progesterone and estradiol or one of its derivatives, a vehicle which allows the systemic passage of said active ingredients, chosen from the group constituted by a solubilizing agent, an absorption promoting agent, a film-forming agent, a gelling agent and their mixtures, in combination or in a mixture with suitable excipients for the realization of a gelled and/or film-forming pharmaceutical form.
Patent MA-28319-A1 (MA)
Title: Preparation medicinale pour la therapie naturelle de la lithiase renale et des infections urinaires
Inventor: ALAMI OUAHABI FOUZIYA
Filed: 2005-05-20
Abstract: «PREPARATION MEDICINALE POUR LA THERAPIE NATURELLE DE LA LITHIASE RENALE ET DES INFECTIONS URINAIRES» Il s'agit d'un produit naturel à base de miel, de safran (pistil) et de gomme arabique. Il agit en fragmentant et éliminant les particules et boues issues de l'aggrégation des calculs formés dans le rein et dont la taille empêchait l'évacuation des calculs par les voies urinaires lors de la miction. Une cure avec cette Préparation combat également les infections urinaires récidivantes et favorise l'élimination des douleurs lombaires. Elle agit efficacement en soulageant le malade des mictions fréquentes et douloureuses et évite au malade le piège de l'insuffisance rénale, de la dialyse ou de la greffe de rein.
Patent MA-28105-A1 (MA)
Title: Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des dyslipidemies et des maladies associees aux dyslipidemies et/ou a l'obesite
Inventor: ARNONE MICHELE
IPC: A61P9/00
Filed: 2006-04-24
Abstract: Utilisation d'un composé antagoniste des récepteurs CB1 aux cannabinoïdes, dérivé du pyrazole, choisi parmi le rimonabant et le N-pipéridino-5-(4-bromophényl) -1-(2,4-dichlorophényl) -4-ethylpyrazole-3-carboxamide, seul ou associé à un autre principe actif, pour la préparation de médicaments utiles dans la prévention et le traitement des dyslipidémies et des maladies associées aux dyslipidémies et/ou à l'obésité telles que le syndrome métabolique, les risques cardiovasculaires et les maladies hépatiques.
Patent MA-37706-A1 (MA)
Title: Procédé de valorisation des vins de presse
Inventor: BENAZIZ MOHAMMED
IPC: C12G1/00
Filed: 2014-12-25
Abstract: L’objectif de cette étude est d’explorer la possibilité d’améliorer la préparation des vins depresse marocain de la région meknès avant assemblage avec les vins de goutte. Il s’agitd’élaborer un procédé industriel efficace de traitement des vins de presse à grande échelle.Apres la fin de la fermentation alcoolique les marcs sont presses dans un pressoirpneumatique pour donner les différents vins de presse. Quatre facteurs (xi) (cépage,fractionnement, enzymage et type de gélatine) sont étudies selon un plan d’expériencefactorielle fractionnaire de deux niveaux et quatre facteurs (ordre 24-¹) afin de déterminer lesfacteurs ayant une influence significative au plan statistique sur les réponses (yi) étudiées. Lesrésultats montrent que la séquence de l’opération de fractiomiement des presses, d’ajoutd’enzyme de clarification et des gélatines œnologiques améliorent considérablement lespropriétés physico-chimiques (filtrabilité par la réduction significative (p<0.05) de turbidité etstabilité de la matière colorante) des vins. Sur le plan organoleptique et par rapport auxrésultats du panel de dégustation, il y a amélioration de la qualité gustative des vins presse parla réduction d’une manière significative (p<0.05), de l’intensité de l’amertume et del’astringence. On note que il n’y a pas de différence significative (p>0,05) entre la gélatinesoluble à froid (20g/hl) et la gélatine soluble à chaud (l5g/hl) sur la variation des réponsesphysicochimiques et organoleptiques. Les vins de presse traités sont stockes durant 5 mois,selon le test de comparaison de deux séries de mesures appariées on a noté une diminutionsignificative de l’indice phénolique total (p<0,05) et de la quantité des anthocyanes totaux(p<0,05) par contre on note une augmentation non significative (p>0,05) de l’intensité decouleur mais significative (p<0,05) de l’amertume pour une quantité des tanins et uneintensité de l’astringence stable (p>0,05).